Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cilnidipine (10mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg) Tablet
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu ALu
Packaging
10x15
Price
₹199/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Telbolife Trio 25 Tablet is a fixed-dose combination used in the effective management of hypertension (high blood pressure) and cardiovascular risk reduction. It contains Telmisartan, an angiotensin II receptor blocker (ARB) that relaxes blood vessels; Cilnidipine, a calcium channel blocker that lowers blood pressure by preventing calcium influx in blood vessel walls; and Metoprolol Succinate, a cardio-selective beta-blocker that reduces heart rate and myocardial oxygen demand. This triple-drug combination offers synergistic control of blood pressure, improved arterial compliance, and protection against heart-related complications.
Common side effects may include dizziness, fatigue, headache, slow heart rate, swelling of ankles (edema), or gastrointestinal discomfort. Rarely, it may cause hypotension, electrolyte imbalance, or liver function disturbances. Patients should seek immediate medical advice if they experience symptoms like persistent cough, chest pain, or severe dizziness.
Telbolife Trio 25 Tablet is indicated for the treatment of essential hypertension, particularly in patients who require a combination therapy for optimal blood pressure control. It is also beneficial in reducing cardiovascular events in hypertensive patients with coexisting conditions like diabetes, coronary artery disease, or left ventricular hypertrophy. The combination offers enhanced efficacy with improved patient adherence.
Should be used under medical supervision, especially in patients with liver, kidney, or heart disorders. Avoid abrupt discontinuation. Not recommended during pregnancy or lactation unless prescribed. Monitor blood pressure and heart rate regularly during treatment.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.
Composition : Telmisartan (40mg) Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) Bilayered
Composition : Telmisartan 20 mg Tablet
Composition : Telmisartan (40mg)
Composition : Telmisartan 80mg Tablet
Composition : Telmisartan (80mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 6.25mg
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg
Composition : Telmisartan (40mg) + Metoprolol Succinate (50mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Telbolife Trio 25 ER Tablet has strong demand in the cardiac and hypertension management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of hypertension (high blood pressure), cardiovascular risk management, and heart-related complications associated with uncontrolled BP. Cilnidipine 10mg helps relax blood vessels and improve blood flow Metoprolol Succinate 25mg helps control heart rate and reduce cardiac workload Telmisartan 40mg helps lower blood pressure by blocking angiotensin receptors Together, this triple-combination ER tablet provides comprehensive blood pressure control and cardiovascular protection, strengthening a reliable cardiac-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telbolife Trio 25 ER Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong cardiologist and physician prescriptions, chronic long-term therapy demand, high growth in cardiac medicines, reliable supply chain support, and good margins in cardiovascular products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.